In addition, human breast cancer cell treatment with nicotinamide induces cellular apoptosis in vivo through Sirt1 inhibition [88], although a recent study points to the fact that nicotinamide addition to cells can stimulate sirtuins due to rapid in vivo conversion of nicotinamide to NAD+ [89]. Here, SIRT1 is linked to breast cancer.